CG Oncology
engineered to promote tumor selectivity and anti tumor potency wild type | CG Oncology
Company
Deck Type
IPO
Deck date
March 2024
Slide
38 of 45
Related slides by other companies
Investor Day
November 2022
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io